HOME >> BIOLOGY >> NEWS
Early mammals used pelvic bones to trot, study finds

exactly like the fossils we have of mammals that lived millions of years ago," said Reilly, who has studied the evolution of animal locomotion for seven years. "We believe the earliest mammals probably moved just like the opossums because they're very similar anatomically."

Reilly and his collaborator Thomas White suspect that the development of epipubic bones made the prehistoric creatures more mobile. The increased locomotion made them better predators, helped them to escape predators and allowed them to forage more widely. "Locomotion contributed heavily to the evolution of mammals," Reilly said, "and these bones had something to do with increasing locomotor efficiency in the very earliest mammals."

As the mammals radiated after the dinosaurs went extinct, the epipubic bones in most mammals, including humans, became fused with the pelvis, which allowed mammals to use many gaits besides the trot.

The findings could have implications for paleontologists, Reilly said.

"If the function of the epipubic bone relates to locomotion, that makes the bones more important as a fossil indicator of increased locomotor efficiency," he said. If scientists study the fossil record and figure out when these bones first appeared, he added, it would shed light on a crucial step in the evolution of mammals.

The research is part of a larger study by Reilly and Ohio University colleague Audrone Biknevicius focusing on the evolution of locomotion, which is funded by a three-year, $295,000 National Science Foundation grant.


'"/>

Contact: Steve Reilly
reilly@ohio.edu
740-593-0424
Ohio University
16-Jan-2003


Page: 1 2

Related biology news :

1. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
2. Early detection hope for eye disease
3. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
4. Early dexamethasone exposure has long-term neurodevelopment, neuroendocrine effects
5. Early predictor of breast cancer aggressiveness
6. Early treatment confirmed as key to stroke recovery
7. Early identification of kidney disease cost-effective only when directed at high-risk patients
8. Early promise for treatment of Ebola
9. Early treatment can prevent severe vision loss in premature infants
10. Early hominids may have behaved more human than we had thought
11. Early infection and rejection detection

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):
(Date:2/18/2017)... Research and Markets has announced the addition of the ... offering. ... report provides separate comprehensive analytics for the US, Japan ... Annual estimates and forecasts are provided for the period 2015 through ... Market data and analytics are derived from primary and secondary research. ...
(Date:2/17/2017)... 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) ... oral peptide drug candidates, PTG-100 and PTG-200, at ... Crohn,s and Colitis Organization (ECCO).  The ECCO congress ... from February 15 – 18, 2017. ... on Protagonist drug candidates PTG-100 and PTG-200. PTG-100, ...
(Date:2/16/2017)... BEACH, Fla. , Feb. 16, 2017 /PRNewswire/ ... company revolutionizing the development of liquid biopsy tests ... has entered into an exclusive license agreement with ... distribute MDNA,s proprietary liquid biopsy test for prostate ... South Korea . This is the ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
Breaking Biology Technology:
Cached News: